Could the fact that they are doing pre-clinicals out of country be a bad thing? Like, say its approved..then there's a plus to doing them out of country? say we get deneied..then pre-clinicals in brazil!?!? Just a thought. What are your opinions? I'm a optimistic person and I believe its in the bag with BMSN approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.